BioAgilytix Boston (previously Cambridge Biomedical Inc.) Email Format

BiotechnologyMassachusetts, United States11-50 Employees

BioAgilytix Boston is a biotechnology research laboratory focused on large-molecule bioanalysis. It operates as part of a global network with laboratories in the Boston-Cambridge area, North Carolina’s Research Triangle, and Hamburg, Germany. The company provides biomarker, immunogenicity, and cell-based assay services, along with pharmacokinetic analyses, to support the development and release testing of biologics. Its offerings include assay development and validation, sample analysis, and GMP quality-control testing such as product release and stability testing, with work conducted under non-GLP, GLP, and GCP frameworks.

Its customers are pharmaceutical and biotechnology developers seeking comprehensive analytical support across preclinical through development stages for biologics across multiple industries and disease areas. The organization describes itself as a global bioanalytical services provider, reinforcing its presence across U.S. and European markets. In 2025, BioAgilytix expanded facilities to Durham, North Carolina, and Europe and launched an LC/MS portfolio to broaden its capabilities. The operation originated as Cambridge Biomedical Inc., now operating under the BioAgilytix brand in Boston.

Sign up for free to view info

Company overview Employee directory